Lawrence Schwartz

Lawrence Schwartz at Columbia University is an expert in cancer imaging and was a key contributor to the development and revision of RECIST (Response Evaluation Criteria in Solid Tumors) criteria. His work has defined how tumor response is measured in oncology clinical trials and informed regulatory approval endpoints. He has contributed to immunotherapy response criteria (iRECIST) and volumetric response assessment methods. His expertise in quantitative imaging endpoints has made him a key resource for oncology drug development collaborations.